Relapsing MS Pill Treatments - Biogen Options
WEBVUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults
FDA Approves First Biosimilar Drug for MS - Healthline
WEBAug 28, 2023 · The Food and Drug Administration approved the first biosimilar to treat relapsing forms of multiple sclerosis this month. The drug is also approved as a treatment for adults with moderately...
VUMERITY® (diroximel fumarate), an oral medication
WEBVUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
FDA Approves First Biosimilar to Treat Multiple Sclerosis
WEBThe U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Official Patient Website | Tecfidera® (dimethyl fumarate)
WEBTECFIDERA ® (dimethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if TECFIDERA is safe and effective in children under 18 years of age.
AVONEX® (interferon beta-1a) | Official Patient Site
WEBYou are eligible to enroll in the Biogen Copay Program for as long as it is offered and you are treated with AVONEX. Stay connected. Get the latest information about relapsing MS and AVONEX. Sign up to get a free brochure, our newsletters, and personalized support from Biogen Support Services.
Multiple Sclerosis - Biogen
WEBAs pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and disability progression.
TYSABRI® (natalizumab) | Official Patient Website
WEBTYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML).
Relapsing MS Treatment | PLEGRIDY® (peginterferon beta-1a)
WEBPLEGRIDY is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
Milestones in multiple sclerosis: Biogen’s commitment to
WEBBiogen’s recombinant humanized monoclonal antibody, natalizumab (TYSABRI®), mediates lymphocyte and monocyte cell adhesion and transendothelial migration via the α4β1 integrin pathway.